Logo image of INM

INMED PHARMACEUTICALS INC (INM) Stock Analyst Earnings Estimates

NASDAQ:INM - Nasdaq - CA4576377002 - Common Stock

5.05  +0.1 (+2.02%)

Premarket: 4.41 -0.64 (-12.67%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024
Revenue
YoY % growth
INM revenue by date.INM revenue by date.
1.09M4.14M
279.82%		4.598M
11.06%
EBITDA
YoY % growth
INM ebitda by date.INM ebitda by date.
-13.4M
-36.46%		-8.18M
38.96%		-7.915M
3.24%
EBIT
YoY % growth
INM ebit by date.INM ebit by date.
-13.59M
-36.72%		-8.38M
38.34%		-8.134M
2.93%
Operating Margin
INM operating margin by date.INM operating margin by date.
-1,246.79%-202.42%-176.92%
EPS
YoY % growth
INM eps by date.INM eps by date.
-34.28
95.46%		N/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2022
Q2Q % growth		 -14.03
-36.88%		-5.56-8.48-152.57%
Q3 2022
Q2Q % growth		 -6.25
39.02%		-6.310.060.99%
Q2 2022
Q2Q % growth		 -7.75
24.39%		-5.93-1.82-30.61%
Q1 2022
Q2Q % growth		 -6.25
-1,424.39%		-8.842.5929.28%
Q4 2021
Q2Q % growth		 -10.25
-2,400.00%		-8.59-1.66-19.39%
Q3 2021
Q2Q % growth		 -10.25 -6.06-4.19-69.14%
Q2 2021
Q2Q % growth		 -10.25 -6.06-4.19-69.14%
Q1 2021
Q2Q % growth		 -0.41 -6.065.6593.23%
Q4 2020
Q2Q % growth		 -0.41 -6.065.6593.23%
INM Yearly EPS VS EstimatesINM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth		 1.265M
40.52%		%
Q4 2024
Q2Q % growth		 1.283M
-44.46%		%
Q3 2024
Q2Q % growth		 1.173M
13.84%		%
Q2 2024
Q2Q % growth		 1.24M
163.83%		%
Q1 2024
Q2Q % growth		 900K
181.25%		%
Q4 2023
Q2Q % growth		 2.31M
352.94%		%
Q3 2023
Q2Q % growth		 1.03M
232.26%		%
Q2 2023
Q2Q % growth		 470K
74.07%		%
Q4 2022
Q2Q % growth		 510K 757.5K-247.5K-32.67%
Q3 2022
Q2Q % growth		 310K 606K-296K-48.84%
Q2 2022
Q2Q % growth		 270K 126.25K143.75K113.86%
Q1 2022
Q2Q % growth		 252.5K-252.5K-100.00%
INM Yearly Revenue VS EstimatesINM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A